国际生物制品学杂志
國際生物製品學雜誌
국제생물제품학잡지
INTERNATIONAL JOURNAL OF BIOLOGICALS
2012年
5期
233-236
,共4页
戴智勤%唐继海%张伟青%易厦晖%刘丹青%何纳
戴智勤%唐繼海%張偉青%易廈暉%劉丹青%何納
대지근%당계해%장위청%역하휘%류단청%하납
麻疹疫苗%强化免疫活动%预防接种异常反应%监测
痳疹疫苗%彊化免疫活動%預防接種異常反應%鑑測
마진역묘%강화면역활동%예방접충이상반응%감측
Measles vaccine%Supplementary immunization activity%Adverse events following immunization%Surveillance
目的 了解安徽省2009年麻疹疫苗强化免疫活动(supplementary immunization activity,SIA)中,疑似预防接种异常反应(adverse events following immunization,AEFI)的发生特征,探讨麻疹疫苗的安全性.方法 采用描述性流行病学方法,对AEFI监测系统中的相关数据进行统计分析.结果 安徽省2009年麻疹疫苗SIA共报告AEFI 41例,AEFI报告发生率3.86/100万剂.78.05％ AEFI发生于接种后1d以内,82.93％ AEFI发生于接种第1剂麻疹疫苗后.临床损害以发热、过敏性皮疹等为主.结论 安徽省2009年SIA的麻疹疫苗安全性良好.接种麻疹疫苗后≤1d是AEFI的监测重点.
目的 瞭解安徽省2009年痳疹疫苗彊化免疫活動(supplementary immunization activity,SIA)中,疑似預防接種異常反應(adverse events following immunization,AEFI)的髮生特徵,探討痳疹疫苗的安全性.方法 採用描述性流行病學方法,對AEFI鑑測繫統中的相關數據進行統計分析.結果 安徽省2009年痳疹疫苗SIA共報告AEFI 41例,AEFI報告髮生率3.86/100萬劑.78.05％ AEFI髮生于接種後1d以內,82.93％ AEFI髮生于接種第1劑痳疹疫苗後.臨床損害以髮熱、過敏性皮疹等為主.結論 安徽省2009年SIA的痳疹疫苗安全性良好.接種痳疹疫苗後≤1d是AEFI的鑑測重點.
목적 료해안휘성2009년마진역묘강화면역활동(supplementary immunization activity,SIA)중,의사예방접충이상반응(adverse events following immunization,AEFI)적발생특정,탐토마진역묘적안전성.방법 채용묘술성류행병학방법,대AEFI감측계통중적상관수거진행통계분석.결과 안휘성2009년마진역묘SIA공보고AEFI 41례,AEFI보고발생솔3.86/100만제.78.05％ AEFI발생우접충후1d이내,82.93％ AEFI발생우접충제1제마진역묘후.림상손해이발열、과민성피진등위주.결론 안휘성2009년SIA적마진역묘안전성량호.접충마진역묘후≤1d시AEFI적감측중점.
Objective To analyze the characteristics and the patterns of adverse events following immunization (AEFI) after the supplementary immunization activity (SIA) of measles vaccine in Anhui Province in 2009 and evaluate the safety of measles vaccine.Methods The data from AEFI surveillance system were analyzed by descriptive epidemiology.Results Forty-one cases of AEFI were reported in measles vaccine SIA in Anhui Province in 2009.The reported incidence was 3.86 per million doses.78.05％ of AEFI occurred within 1 d after vaccination,82.93％ of AEFI occurred after the first dose of vaccination.The reported AEFIs mainly were fever and allergic rash.Conclusions The measles vaccine of SIA in 2009 in Anhui Province is safe.More attention should be given to the AEFI surveillance within 1 d after measles vaccination.
